R1 RCM Inc. with ticker code (RCM) now have 15 analysts in total covering the stock. The consensus rating is ‘Buy’. The range between the high target price and low target price is between 25 and 11 with the average target price sitting at 17.63. With the stocks previous close at 14.57 this indicates there is a potential upside of 21.0%. The 50 day MA is 12.46 and the 200 day moving average is 17.72. The market cap for the company is $5,871m. Company Website: https://www.r1rcm.com
The potential market cap would be $7,104m based on the market concensus.
R1 RCM Inc. provides technology-driven solutions that transform the patient experience and financial performance of hospitals, health systems, and physician groups. It offers end-to-end revenue cycle management (RCM) services, which address the spectrum of revenue cycle challenges faced by healthcare providers. The company provides modular services, including physician advisory services, which assists healthcare organizations in complying with payer requirements regarding whether to classify a hospital visit as an in-patient or an out-patient observation case for billing purposes; practice management services that offers administrative and operational support for patient care and outsource non-core functions; revenue integrity solutions, including coding management services, such as business intelligence and analysis, human capital management, accountability framework, and quality management programs; patient experience; and business office services. R1 RCM Inc. was founded in 2003 and is headquartered in Murray, Utah.
